Toll-like receptors are key players in neurodegeneration
Tài liệu tham khảo
Lucas, 2006, The role of inflammation in CNS injury and disease, Br J Pharmacol, 147, S232, 10.1038/sj.bjp.0706400
Rivest, 2009, Regulation of innate immune responses in the brain, Nat Rev Immunol, 9, 429, 10.1038/nri2565
Popovich, 2008, Can the immune system be harnessed to repair the CNS?, Nat Rev Neurosci, 9, 481, 10.1038/nrn2398
Streit, 2002, Microglia as neuroprotective, immunocompetent cells of the CNS, Glia, 40, 133, 10.1002/glia.10154
Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016
Iribarren, 2005, IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia, J Immunol, 175, 6100, 10.4049/jimmunol.175.9.6100
Kawai, 2010, The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat Immunol, 11, 373, 10.1038/ni.1863
Medzhitov, 2007, Recognition of microorganisms and activation of the immune response, Nature, 449, 819, 10.1038/nature06246
Barton, 2009, A cell biological view of Toll-like receptor function: regulation through compartmentalization, Nat Rev Immunol, 9, 535, 10.1038/nri2587
O'Neill, 2003, The Toll-IL-1 receptor adaptor family grows to five members, Trends Immunol, 24, 286, 10.1016/S1471-4906(03)00115-7
Motshwene, 2009, An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4, J Biol Chem, 284, 25404, 10.1074/jbc.M109.022392
Horng, 2002, The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors, Nature, 420, 329, 10.1038/nature01180
Yamamoto, 2002, Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4, Nature, 420, 324, 10.1038/nature01182
Peng, 2010, SARM inhibits both TRIF- and MyD88-mediated AP-1 activation, Eur J Immunol, 40, 1738, 10.1002/eji.200940034
Chaturvedi, 2009, How location governs toll-like receptor signaling, Traffic, 10, 621, 10.1111/j.1600-0854.2009.00899.x
Kagan, 2008, TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta, Nat Immunol, 9, 361, 10.1038/ni1569
McKimmie, 2005, Viruses selectively upregulate Toll-like receptors in the central nervous system, Biochem Biophys Res Commun, 336, 925, 10.1016/j.bbrc.2005.08.209
Zekki, 2002, The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS, Brain Pathol, 12, 308, 10.1111/j.1750-3639.2002.tb00445.x
Iribarren, 2005, CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1–42 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2, FASEB J, 19, 2032, 10.1096/fj.05-4578fje
Bsibsi, 2002, Broad expression of Toll-like receptors in the human central nervous system, J Neuropathol Exp Neurol, 61, 1013, 10.1093/jnen/61.11.1013
Bowman, 2003, Cultured astrocytes express toll-like receptors for bacterial products, Glia, 43, 281, 10.1002/glia.10256
Carpentier, 2008, Glial toll-like receptor signaling in central nervous system infection and autoimmunity, Brain Behav Immun, 22, 140, 10.1016/j.bbi.2007.08.011
Suh, 2007, Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response, J Virol, 81, 9838, 10.1128/JVI.00792-07
Hamby, 2006, Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes, J Neurosci Methods, 150, 128, 10.1016/j.jneumeth.2005.06.016
Saura, 2007, Microglial cells in astroglial cultures: a cautionary note, J Neuroinflammation, 4, 26, 10.1186/1742-2094-4-26
Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat Rev Neurosci, 8, 57, 10.1038/nrn2038
Konat, 2006, The role of Toll-like receptors in CNS response to microbial challenge, J Neurochem, 99, 1, 10.1111/j.1471-4159.2006.04076.x
Olson, 2004, Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs, J Immunol, 173, 3916, 10.4049/jimmunol.173.6.3916
Chakravarty, 2005, Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines, J Neurosci, 25, 1788, 10.1523/JNEUROSCI.4268-04.2005
Tang, 2007, Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits, Proc Natl Acad Sci USA, 104, 13798, 10.1073/pnas.0702553104
Mishra, 2008, Expression and distribution of Toll-like receptors 11–13 in the brain during murine neurocysticercosis, J Neuroinflammation, 5, 53, 10.1186/1742-2094-5-53
Kim, 2007, A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity, J Biol Chem, 282, 14975, 10.1074/jbc.M607277200
Ma, 2007, TLR8: an innate immune receptor in brain, neurons and axons, Cell Cycle, 6, 2859, 10.4161/cc.6.23.5018
Prehaud, 2005, Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon, J Virol, 79, 12893, 10.1128/JVI.79.20.12893-12904.2005
Jackson, 2006, Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases, J Neurovirol, 12, 229, 10.1080/13550280600848399
Cameron, 2007, Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals, J Neurosci, 27, 13033, 10.1523/JNEUROSCI.4290-06.2007
Lathia, 2008, Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation, J Neurosci, 28, 13978, 10.1523/JNEUROSCI.2140-08.2008
Chen, 2006, Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide, J Biol Chem, 281, 3651, 10.1074/jbc.M508125200
Sadik, 2003, The increasing burden of Alzheimer disease, Alzheimer Dis Assoc Disord, 17, S75, 10.1097/00002093-200307003-00003
Dickson, 1997, The pathogenesis of senile plaques, J Neuropathol Exp Neurol, 56, 321, 10.1097/00005072-199704000-00001
Selkoe, 2001, Alzheimer's disease: genes, proteins, and therapy, Physiol Rev, 81, 741, 10.1152/physrev.2001.81.2.741
Citron, 1996, Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities, Proc Natl Acad Sci USA, 93, 13170, 10.1073/pnas.93.23.13170
Cotter, 1999, Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity, J Leukoc Biol, 65, 416, 10.1002/jlb.65.4.416
Iribarren, 2007, Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia, Neurobiol Dis, 27, 90, 10.1016/j.nbd.2007.04.010
Cui, 2002, Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells, J Immunol, 168, 434, 10.4049/jimmunol.168.1.434
McKimmie, 2005, In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression, J Neuroimmunol, 169, 116, 10.1016/j.jneuroim.2005.08.006
Bamberger, 2003, A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation, J Neurosci, 23, 2665, 10.1523/JNEUROSCI.23-07-02665.2003
Reed-Geaghan, 2009, CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation, J Neurosci, 29, 11982, 10.1523/JNEUROSCI.3158-09.2009
Liu, 2005, LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide, Brain, 128, 1778, 10.1093/brain/awh531
Tahara, 2006, Role of toll-like receptor signalling in Abeta uptake and clearance, Brain, 129, 3006, 10.1093/brain/awl249
Richard, 2008, Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1–42 and delay the cognitive decline in a mouse model of Alzheimer's disease, J Neurosci, 28, 5784, 10.1523/JNEUROSCI.1146-08.2008
Le, 2001, Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1, J Neurosci, 21, 10.1523/JNEUROSCI.21-02-j0003.2001
Scholtzova, 2009, Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology, J Neurosci, 29, 1846, 10.1523/JNEUROSCI.5715-08.2009
Weiner, 2004, Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease, Arch Neurol, 61, 1613, 10.1001/archneur.61.10.1613
Rasmussen, 2007, Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing–remitting experimental autoimmune encephalomyelitis, Brain, 130, 2816, 10.1093/brain/awm219
Kutzelnigg, 2005, Cortical demyelination and diffuse white matter injury in multiple sclerosis, Brain, 128, 2705, 10.1093/brain/awh641
Prinz, 2006, Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis, J Clin Invest, 116, 456, 10.1172/JCI26078
Farez, 2009, Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE, Nat Immunol, 10, 958, 10.1038/ni.1775
Herrmann, 2006, Streptococcus pneumoniae infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2, Infect Immun, 74, 4841, 10.1128/IAI.00026-06
Marta, 2008, Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis, Eur J Immunol, 38, 565, 10.1002/eji.200737187
Touil, 2006, Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta, J Immunol, 177, 7505, 10.4049/jimmunol.177.11.7505